102 related articles for article (PubMed ID: 9166729)
1. Chronic exposure to kappa-opioids enhances the susceptibility of immortalized neurons (F-11kappa 7) to apoptosis-inducing drugs by a mechanism that may involve ceramide.
Dawson G; Dawson SA; Goswami R
J Neurochem; 1997 Jun; 68(6):2363-70. PubMed ID: 9166729
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-11kappa7) neurons.
Goswami R; Dawson SA; Dawson G
J Neurochem; 1998 Apr; 70(4):1376-82. PubMed ID: 9523553
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of apoptosis in embryonic cortical neurons (E6 and E7) in culture involve lipid signalling, protein phosphorylation and caspase activation.
Dawson G
Int J Dev Neurosci; 2000; 18(2-3):247-57. PubMed ID: 10715579
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevents formation of ceramide in response to pro-apoptotic stimuli.
Goswami R; Kilkus J; Dawson SA; Dawson G
J Neurosci Res; 1999 Sep; 57(6):884-93. PubMed ID: 10467260
[TBL] [Abstract][Full Text] [Related]
5. kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids.
Gurwell JA; Duncan MJ; Maderspach K; Stiene-Martin A; Elde RP; Hauser KF
Brain Res; 1996 Oct; 737(1-2):175-87. PubMed ID: 8930364
[TBL] [Abstract][Full Text] [Related]
6. Programmed cell death in neurotumour cells involves the generation of ceramide.
Wiesner DA; Dawson G
Glycoconj J; 1996 Apr; 13(2):327-33. PubMed ID: 8737258
[TBL] [Abstract][Full Text] [Related]
7. Multiple polyphosphoinositide pathways regulate apoptotic signalling in a dorsal root ganglion derived cell line.
Goswami R; Dawson SA; Dawson G
J Neurosci Res; 2000 Jan; 59(1):136-44. PubMed ID: 10658194
[TBL] [Abstract][Full Text] [Related]
8. kappa-Opioid tolerance and dependence in cultures of dopaminergic midbrain neurons.
Dalman FC; O'Malley KL
J Neurosci; 1999 Jul; 19(14):5750-7. PubMed ID: 10407016
[TBL] [Abstract][Full Text] [Related]
9. The formation of ceramide from sphingomyelin is associated with cellular apoptosis.
Dawson G; Goswami R; Kilkus J; Wiesner D; Dawson S
Acta Biochim Pol; 1998; 45(2):287-97. PubMed ID: 9821861
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T
J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192
[TBL] [Abstract][Full Text] [Related]
11. Suppression of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated aryl hydrocarbon receptor transformation and CYP1A1 induction by the phosphatidylinositol 3-kinase inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one (LY294002).
Guo M; Joiakim A; Reiners JJ
Biochem Pharmacol; 2000 Sep; 60(5):635-42. PubMed ID: 10927021
[TBL] [Abstract][Full Text] [Related]
12. Lack of cross-tolerance between U69,593 and bremazocine suggests kappa-opioid receptor multiplicity in mice.
Horan PJ; Porreca F
Eur J Pharmacol; 1993 Aug; 239(1-3):93-8. PubMed ID: 8223918
[TBL] [Abstract][Full Text] [Related]
13. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway.
Wiesner DA; Dawson G
J Neurochem; 1996 Apr; 66(4):1418-25. PubMed ID: 8627293
[TBL] [Abstract][Full Text] [Related]
14. Neurosteroids enhance the viability of staurosporine and doxorubicin treated differentiated human neuroblastoma SH-SY5Y cells.
Leśkiewicz M; Regulska M; Budziszewska B; Jantas D; Jaworska-Feil L; Basta-Kaim A; Kubera M; Lasoń W
Pharmacol Rep; 2008; 60(5):685-91. PubMed ID: 19066415
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I.
Ryu BR; Ko HW; Jou I; Noh JS; Gwag BJ
J Neurobiol; 1999 Jun; 39(4):536-46. PubMed ID: 10380075
[TBL] [Abstract][Full Text] [Related]
16. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase and protein kinase C are required for the inhibition of caspase activity by epidermal growth factor.
Lan L; Wong NS
FEBS Lett; 1999 Feb; 444(1):90-6. PubMed ID: 10037154
[TBL] [Abstract][Full Text] [Related]
18. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
Horan P; de Costa BR; Rice KC; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325
[TBL] [Abstract][Full Text] [Related]
19. kappa-Opioid binding sites on a murine lymphoma cell line.
Bidlack JM; Saripalli LD; Lawrence DM
Eur J Pharmacol; 1992 Nov; 227(3):257-65. PubMed ID: 1335414
[TBL] [Abstract][Full Text] [Related]
20. Differential agonist regulation of the human kappa-opioid receptor.
Blake AD; Bot G; Li S; Freeman JC; Reisine T
J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
